Cancer Drugs Should Cost Less, Say Doctors
Education Rethink 2013-04-29
Summary:
Doctors argue that some drug companies are charging too much for their cancer drugs, to the detriment of patients.
A group of more than 100 cancer experts have called out drug companies for the high prices of cancer drugs. The doctors, all specialists in chronic myelogenous leukemia or CML, published their opinion on what they call “astronomical” prices on Friday in the scientific journal Blood.